Literature DB >> 27163172

Mixed-ligand copper(ii) Schiff base complexes: the role of the co-ligand in DNA binding, DNA cleavage, protein binding and cytotoxicity.

Wen-Jing Lian1, Xin-Tian Wang1, Cheng-Zhi Xie1, He Tian1, Xue-Qing Song1, He-Ting Pan1, Xin Qiao1, Jing-Yuan Xu1.   

Abstract

Four novel mononuclear Schiff base copper(ii) complexes, namely, [Cu(L)(OAc)]·H2O (), [Cu(HL)(C2O4)(EtOH)]·EtOH (), [Cu(L)(Bza)] () and [Cu(L)(Sal)] () (HL = 1-(((2-((2-hydroxypropyl)amino)ethyl)imino)methyl)naphthalene-2-ol), Bza = benzoic acid, Sal = salicylic acid), were synthesized and characterized by X-ray crystallography, elemental analysis and infrared spectroscopy. Single-crystal diffraction analysis revealed that all the complexes were mononuclear molecules, in which the Schiff base ligand exhibited different coordination modes and conformations. The N-HO and O-HO inter- and intramolecular hydrogen bonding interactions linked these molecules into multidimensional networks. Their interactions with calf thymus DNA (CT-DNA) were investigated by UV-visible and fluorescence spectrometry, as well as by viscosity measurements. The magnitude of the Kapp values of the four complexes was 10(5), indicating a moderate intercalative binding mode between the complexes and DNA. Electrophoresis results showed that all these complexes induced double strand breaks of pUC19 plasmid DNA in the presence of H2O2 through an oxidative pathway. In addition, the fluorescence spectrum of human serum albumin (HSA) with the complexes suggested that the quenching mechanism of HSA by the complexes was a static process. Moreover, the antiproliferative activity of the four complexes against HeLa (human cervical carcinoma) and HepG-2 (human liver hepatocellular carcinoma) cells evaluated by colorimetric cell proliferation assay and clonogenic assay revealed that all four complexes had improved cytotoxicity against cancer cells. Inspiringly, complex , with salicylic acid as the auxiliary ligand, displayed a stronger anticancer activity, suggesting that a synergistic effect of the Schiff base complex and the nonsteroidal anti-inflammatory drug may be involved in the cell killing process. The biological features of mixed-ligand copper(ii) Schiff base complexes and how acetic auxiliary ligands manipulate these features are also discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27163172     DOI: 10.1039/c6dt00461j

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  9 in total

1.  One pot synthesis of two cobalt(iii) Schiff base complexes with chelating pyridyltetrazolate and exploration of their bio-relevant catalytic activities.

Authors:  Kousik Ghosh; Abhisek Banerjee; Antonio Bauzá; Antonio Frontera; Shouvik Chattopadhyay
Journal:  RSC Adv       Date:  2018-08-07       Impact factor: 4.036

2.  Docking and in vitro molecular biology studies of p-anisidine-appended 1-hydroxy-2-acetonapthanone Schiff base lanthanum(iii) complexes.

Authors:  V Sathiyanarayanan; P Varun Prasath; P Chandra Sekhar; K Ravichandran; D Easwaramoorthy; Faruq Mohammad; Hamad A Al-Lohedan; Won Chun Oh; Suresh Sagadevan
Journal:  RSC Adv       Date:  2020-04-24       Impact factor: 4.036

3.  Stabilization of two conformers via intra- or inter-molecular hydrogen bonds in a dinuclear vanadium(v) complex with a pendant Schiff base: theoretical insight.

Authors:  Snehasish Thakur; Michael G B Drew; Antonio Franconetti; Antonio Frontera; Shouvik Chattopadhyay
Journal:  RSC Adv       Date:  2019-11-06       Impact factor: 4.036

4.  An investigation on 3-acetyl-7-methoxy-coumarin Schiff bases and their Ru(ii) metallates with potent antiproliferative activity and enhanced LDH and NO release.

Authors:  G Kalaiarasi; S Rex Jeya Rajkumar; S Dharani; J G Małecki; R Prabhakaran
Journal:  RSC Adv       Date:  2018-01-04       Impact factor: 4.036

Review 5.  Transition Metal Intercalators as Anticancer Agents-Recent Advances.

Authors:  Krishant M Deo; Benjamin J Pages; Dale L Ang; Christopher P Gordon; Janice R Aldrich-Wright
Journal:  Int J Mol Sci       Date:  2016-10-31       Impact factor: 5.923

Review 6.  Metal complexes in cancer therapy - an update from drug design perspective.

Authors:  Umar Ndagi; Ndumiso Mhlongo; Mahmoud E Soliman
Journal:  Drug Des Devel Ther       Date:  2017-03-03       Impact factor: 4.162

7.  Design, synthesis and characterization of novel chromone based-copper(ii) antitumor agents with N,N-donor ligands: comparative DNA/RNA binding profile and cytotoxicity.

Authors:  Farukh Arjmand; Zeenat Afsan; Thierry Roisnel
Journal:  RSC Adv       Date:  2018-11-06       Impact factor: 4.036

8.  Spectro-electrochemical assessments of DNA/BSA interactions, cytotoxicity, radical scavenging and pharmacological implications of biosensitive and biologically active morpholine-based metal(ii) complexes: a combined experimental and computational investigation.

Authors:  Karunganathan Sakthikumar; Rajadurai Vijay Solomon; Jeyaraj Dhaveethu Raja
Journal:  RSC Adv       Date:  2019-05-07       Impact factor: 4.036

Review 9.  Copper signalling: causes and consequences.

Authors:  Julianna Kardos; László Héja; Ágnes Simon; István Jablonkai; Richard Kovács; Katalin Jemnitz
Journal:  Cell Commun Signal       Date:  2018-10-22       Impact factor: 5.712

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.